EQA round – Antimicrobial susceptibility testing (AST)

The Institut Pasteur, consortium member of the EURL-PH-DIPE, is launching the first round of External Quality Assessment (EQA). This initiative aims to assess the current capabilities of national reference laboratories across EU/EEA Member States in the detection of macrolide-resistant B. pertussis isolates.

The recruiting phase was launched in March and has been completed. The panel shipments are soon to take place.